169 related articles for article (PubMed ID: 11073664)
21. Arylfurans as potential trypanosoma cruzi trypanothione reductase inhibitors.
de Oliveira RB; Vaz AB; Alves RO; Liarte DB; Donnici CL; Romanha AJ; Zani CL
Mem Inst Oswaldo Cruz; 2006 Mar; 101(2):169-73. PubMed ID: 16830710
[TBL] [Abstract][Full Text] [Related]
22. Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design.
Saravanamuthu A; Vickers TJ; Bond CS; Peterson MR; Hunter WN; Fairlamb AH
J Biol Chem; 2004 Jul; 279(28):29493-500. PubMed ID: 15102853
[TBL] [Abstract][Full Text] [Related]
23. Betraying the parasite's redox system: diaryl sulfide-based inhibitors of trypanothione reductase: subversive substrates and antitrypanosomal properties.
Stump B; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F
ChemMedChem; 2007 Dec; 2(12):1708-12. PubMed ID: 17918760
[No Abstract] [Full Text] [Related]
24. Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking.
Rodríguez-Becerra J; Cáceres-Jensen L; Hernández-Ramos J; Barrientos L
Mol Divers; 2017 Aug; 21(3):697-711. PubMed ID: 28656524
[TBL] [Abstract][Full Text] [Related]
25. Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme.
Turcano L; Battista T; De Haro ET; Missineo A; Alli C; Paonessa G; Colotti G; Harper S; Fiorillo A; Ilari A; Bresciani A
PLoS Negl Trop Dis; 2020 May; 14(5):e0008339. PubMed ID: 32437349
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, inhibition potency, binding mode, and antiprotozoal activities of fluorescent inhibitors of trypanothione reductase based on mepacrine-conjugated diaryl sulfide scaffolds.
Eberle C; Burkhard JA; Stump B; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F
ChemMedChem; 2009 Dec; 4(12):2034-44. PubMed ID: 19847846
[TBL] [Abstract][Full Text] [Related]
27. Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma.
De Gasparo R; Brodbeck-Persch E; Bryson S; Hentzen NB; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
ChemMedChem; 2018 May; 13(9):957-967. PubMed ID: 29624890
[TBL] [Abstract][Full Text] [Related]
28. Parasite-specific trypanothione reductase as a drug target molecule.
Krauth-Siegel RL; Inhoff O
Parasitol Res; 2003 Jun; 90 Suppl 2():S77-85. PubMed ID: 12709793
[TBL] [Abstract][Full Text] [Related]
29. Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase.
Cavalli A; Lizzi F; Bongarzone S; Brun R; Luise Krauth-Siegel R; Bolognesi ML
Bioorg Med Chem Lett; 2009 Jun; 19(11):3031-5. PubMed ID: 19414258
[TBL] [Abstract][Full Text] [Related]
30. Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines.
Khan MO; Austin SE; Chan C; Yin H; Marks D; Vaghjiani SN; Kendrick H; Yardley V; Croft SL; Douglas KT
J Med Chem; 2000 Aug; 43(16):3148-56. PubMed ID: 10956223
[TBL] [Abstract][Full Text] [Related]
31. Flavoprotein structure and mechanism. 5. Trypanothione reductase and lipoamide dehydrogenase as targets for a structure-based drug design.
Krauth-Siegel RL; Schöneck R
FASEB J; 1995 Sep; 9(12):1138-46. PubMed ID: 7672506
[TBL] [Abstract][Full Text] [Related]
32. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
Beltran-Hortelano I; Perez-Silanes S; Galiano S
Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
[TBL] [Abstract][Full Text] [Related]
33. Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: a divinyl ketone as key intermediate.
Lee B; Bauer H; Melchers J; Ruppert T; Rattray L; Yardley V; Davioud-Charvet E; Krauth-Siegel RL
J Med Chem; 2005 Nov; 48(23):7400-10. PubMed ID: 16279799
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals.
Cunningham ML; Zvelebil MJ; Fairlamb AH
Eur J Biochem; 1994 Apr; 221(1):285-95. PubMed ID: 8168518
[TBL] [Abstract][Full Text] [Related]
35. Photoinactivation of trypanothione reductase and glutathione reductase by Al-phthalocyanine tetrasulfonate and hematoporphyrin.
Kliukiené R; Maroziené A; Cénas N; Becker K; Blanchard JS
Biochem Biophys Res Commun; 1996 Jan; 218(2):629-32. PubMed ID: 8561807
[TBL] [Abstract][Full Text] [Related]
36. A general approach to the synthesis of polyamine linked-monoindolylmaleimides, a new series of trypanothione reductase inhibitors.
Salmon L; Landry V; Melnyk O; Maes L; Sergheraert C; Davioud-Charvet E
Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):707-10. PubMed ID: 9579046
[TBL] [Abstract][Full Text] [Related]
37. Engineering the substrate specificity of glutathione reductase toward that of trypanothione reduction.
Henderson GB; Murgolo NJ; Kuriyan J; Osapay K; Kominos D; Berry A; Scrutton NS; Hinchliffe NW; Perham RN; Cerami A
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8769-73. PubMed ID: 1924337
[TBL] [Abstract][Full Text] [Related]
38. Polyamines with N-(3-phenylpropyl) substituents are effective competitive inhibitors of trypanothione reductase and trypanocidal agents.
Li Z; Fennie MW; Ganem B; Hancock MT; Kobaslija M; Rattendi D; Bacchi CJ; O'Sullivan MC
Bioorg Med Chem Lett; 2001 Jan; 11(2):251-4. PubMed ID: 11206471
[TBL] [Abstract][Full Text] [Related]
39. Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductase.
Angiulli G; Lantella A; Forte E; Angelucci F; Colotti G; Ilari A; Malatesta F
Biochim Biophys Acta; 2015 Sep; 1850(9):1891-7. PubMed ID: 26033467
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of Trypanosoma cruzi trypanothione reductase revealed by virtual screening and parallel synthesis.
Meiering S; Inhoff O; Mies J; Vincek A; Garcia G; Kramer B; Dormeyer M; Krauth-Siegel RL
J Med Chem; 2005 Jul; 48(15):4793-802. PubMed ID: 16033259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
